Mr Mark Rochester
Consultant Urological Surgeon
MA, MB BChir, MD, FRCS(Urol)
I have subspecialty training in urological cancer surgery, particularly for the kidney and bladder and offer minimally invasive (laparoscopic) surgery for these conditions - laparoscopic cystectomy, radical and partial nephrectomy.
I also have expertise in Holmium Laser Enucleation for the Prostate (HoLEP / laser prostatectomy) for benign prostate enlargement and have mentored other surgeons in this new technique. This procedure offers a shorter hospital stay and post-operative catheterisation time than the traditional TURP (TransUrethral Resection of the Prostate) method.
I maintain an active interest in clinical research, currently co-supervising surgeons towards research degrees at UEA and running a randomised trial for patients with chronic pelvic pain funded by a Regional Innovation Fund Grant.
I qualified from Trinity College, Cambridge in 1998 with first class honours in medical sciences. After surgical training in Oxford I undertook a period of full-time laboratory research in urological oncology at the Institute of Molecular Medicine in Oxford, which led to the award of an MD degree and election to the post of Royal College of Surgeons of England Hunterian Professor in 2006. My specialist urology training took place in the Eastern Deanery, predominantly in Norwich and Cambridge.
Some of the principal treatments carried out by Mr Mark Rochester at Spire include:
COVID-19 testing or antibody tests are not available as a standalone service at Spire Norwich Hospital.
British Association of Urological Surgeons
Royal College of Surgeons of England
British Medical Association
European Association of Urology
Kidney, prostate and bladder cancer Chief investigator for SMART-P trial for chronic prostatits / chronic pelvic pain
Consultant Urological Surgeon, Norfolk and Norwich University Hospital NHS Foundation Trust